Melinta Therapeutics Demonstrates Potential of Pyrrolocytosine Candidate against Gonorrhea
New Haven, Conn., June 05, 2017 (GLOBE NEWSWIRE) -- Melinta Therapeutics, a privately held company developing novel antibiotics to treat serious bacterial infections, announced that an oral presentation on the potential of RX-P2177, a novel pyrrolocytosine …